Engineered Phage Tail-Like Bacteriocins as Human Therapeutics
Time: 3:15 pm
day: Conference Day Two
Details:
- Phage tail-like bacteriocins can be retargeted by engineering receptor binding proteins
- These structures have in vivo bactericidal activity and can be used for treatment of infectious disease or microbiome manipulation
- Methodologies can be interchanged with phages
New Company!
